The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
Open accessAbstract
The 2021 guidelines primary panel selected clinically relevant questions and produced updated recommendations, on the basis of important new findings emerging since the 2016 guidelines. In subjects with clinical atherosclerosis, abdominal aortic aneurysm, most subjects with diabetes or chronic kidney disease, and those with low-density lipoprotein cholesterol (LDL-C) ≥5 mmol/L, statin therapy continues to be recommended. We have introduced the concept of lipid/lipoprotein treatment thresholds for intensifying lipid-lowering therapy with non-statin agents, and have identified the secondary prevention patients who have been shown to derive the largest benefit from intensification of therapy with these agents. For all other patients, we emphasize risk assessment linked to lipid/lipoprotein evaluation to optimize clinical decision-making. Lipoprotein(a) measurement is now recommended once in a patient's lifetime, as part of initial lipid screening to assess cardiovascular risk. For any patient with triglycerides ˃1.5 mmol/L, either non-high-density lipoprotein cholesterol or apolipoprotein-B are the preferred lipid parameter for screening, rather than LDL-C. We provide updated recommendations regarding the role of coronary artery calcium scoring as a clinical decision tool to aid the decision to initiate statin therapy. There are new recommendations on the preventative care of women with hypertensive disorders of pregnancy. Health behaviour modification, including regular exercise and a heart-healthy diet, remain the cornerstone of cardiovascular disease prevention. These guidelines are intended to provide a platform for meaningful conversation and shared-decision making between patient and care provider, so that individual decisions can be made for risk screening, assessment, and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Self-citationCholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962
Self-citationAlirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., Harrington, R. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801174 · Cited by 3,634
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
Collaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. J. (2007) · BMJ · doi:10.1136/bmj.39335.385301.be · Cited by 2,552
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle
Stampfer, M. J., Hu, F. B., Manson, J. E., Rimm, E. B., & Willett, W. C. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430103 · Cited by 1,794
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Ray, K. K., Wright, R. S., Kallend, D., Koenig, W., Leiter, L. A., Raal, F. J., Bisch, J. A., Richardson, T., Jaros, M., Wijngaard, P. L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1912387 · Cited by 1,665
Self-citationBorén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Self-citationWang, X., Ouyang, Y., Liu, J., Zhu, M., Zhao, G., Bao, W., & Hu, F. B. (2014) · BMJ · doi:10.1136/bmj.g4490 · Cited by 1,596
Silverman, M. G., Ference, B. A., Im, K., Wiviott, S. D., Giugliano, R. P., Grundy, S. M., Braunwald, E., & Sabatine, M. S. (2016) · JAMA · doi:10.1001/jama.2016.13985 · Cited by 1,483
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Kamstrup, P. R. (2009) · JAMA · doi:10.1001/jama.2009.801 · Cited by 1,357
Anderson, T. J., Grégoire, J., Pearson, G. J., Barry, A. R., Couture, P., Dawes, M., Francis, G. A., Genest, J., Grover, S., Gupta, M., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.510 · Cited by 1,173
Self-citationYeboah, J., McClelland, R. L., Polonsky, T. S., Burke, G. L., Sibley, C. T., O’Leary, D., Carr, J. J., Goff, D. C., Greenland, P., & Herrington, D. M. (2012) · JAMA · doi:10.1001/jama.2012.9624 · Cited by 1,122
Effects of anacetrapib in patients with atherosclerotic vascular disease
The HPS3/TIMI55–REVEAL Collaborative Group (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706444 · Cited by 1,047
Nicholls, S. J., Lincoff, A. M., Garcia, M., Bash, D., Ballantyne, C. M., Barter, P. J., Davidson, M. H., Kastelein, J. J. P., Koenig, W., McGuire, D. K., et al. (2020) · JAMA · doi:10.1001/jama.2020.22258 · Cited by 1,028
Schwingshackl, L., & Hoffmann, G. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2014.12.009 · Cited by 1,022
Ray, J. G., Vermeulen, M. J., Schull, M. J., & Redelmeier, D. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67726-4 · Cited by 1,013
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk: Insights From the FOURIER Trial
O’Donoghue, M. L., Fazio, S., Giugliano, R. P., Stroes, E. S. G., Kanevsky, E., Gouni-Berthold, I., Im, K., Lira Pineda, A., Wasserman, S. M., Češka, R., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037184 · Cited by 984
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Albert, C. M., Gordon, D., Copeland, T., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811403 · Cited by 979
Coronary Calcium Score and Cardiovascular Risk
Greenland, P., Blaha, M. J., Budoff, M. J., Erbel, R., & Watson, K. E. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.027 · Cited by 966
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
Taylor, A. J., Cerqueira, M., Hodgson, J. M., Mark, D., Min, J., O'Gara, P., & Rubin, G. D. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.005 · Cited by 894
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Yusuf, S., Bosch, J., Dagenais, G., Zhu, J., Xavier, D., Liu, L., Pais, P., López-Jaramillo, P., Leiter, L. A., Dans, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600176 · Cited by 848
Self-citationInclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
Raal, F. J., Kallend, D., Ray, K. K., Turner, T., Koenig, W., Wright, R. S., Wijngaard, P. L. J., Curcio, D., Jaros, M. J., Leiter, L. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1913805 · Cited by 818
Self-citationBoekholdt, S. M., Arsenault, B. J., Mora, S., Pedersen, T. R., LaRosa, J. C., Nestel, P. J., Simes, R. J., Durrington, P., Hitman, G. A., Welch, K. M. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.366 · Cited by 795
Anderson, T. J., Grégoire, J., Hegele, R. A., Couture, P., Mancini, G. B. J., McPherson, R., Francis, G. A., Poirier, P., Lau, D. C., Grover, S., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.11.032 · Cited by 770
Self-citationBonaca, M. P., Nault, P., Giugliano, R. P., Keech, A. C., Pineda, A. L., Kanevsky, E., Kuder, J., Murphy, S. A., Jukema, J. W., Lewis, B. S., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032235 · Cited by 766
Raal, F. J., Stein, E. A., Dufour, R., Turner, T., Civeira, F., Burgess, L., Langslet, G., Scott, R., Olsson, A. G., Sullivan, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61399-4 · Cited by 756
Dietary fibre intake and risk of cardiovascular disease: Systematic review and meta-analysis
Threapleton, D. E., Greenwood, D. C., Evans, C. E. L., Cleghorn, C. L., Nykjaer, C., Woodhead, C., Cade, J. E., Gale, C. P., & Burley, V. J. (2013) · BMJ · doi:10.1136/bmj.f6879 · Cited by 749
Raal, F. J., Honarpour, N., Blom, D. J., Hovingh, G. K., Xu, F., Scott, R., Wasserman, S. M., & Stein, E. A. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61374-x · Cited by 734
Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review
Balk, E. M., Lichtenstein, A. H., Chung, M., Kupelnick, B., Chew, P., & Lau, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.012 · Cited by 732
Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
The ASCEND Study Collaborative Group (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804989 · Cited by 698
Budoff, M. J., Young, R., Burke, G., Jeffrey Carr, J., Detrano, R. C., Folsom, A. R., Kronmal, R., Lima, J. A. C., Liu, K. J., McClelland, R. L., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy217 · Cited by 684
Giugliano, R. P., Pedersen, T. R., Park, J.-G., De Ferrari, G. M., Gaciong, Z. A., Ceska, R., Toth, K., Gouni-Berthold, I., Lopez-Miranda, J., Schiele, F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32290-0 · Cited by 682
McClelland, R. L., Jorgensen, N. W., Budoff, M., Blaha, M. J., Post, W. S., Kronmal, R. A., Bild, D. E., Shea, S., Liu, K., Watson, K. E., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.035 · Cited by 681
Diagnostic and Prognostic Value of Absence of Coronary Artery Calcification
Sarwar, A., Shaw, L. J., Shapiro, M. D., Blankstein, R., Hoffman, U., Cury, R. C., Abbara, S., Brady, T. J., Budoff, M. J., Blumenthal, R. S., et al. (2009) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2008.12.031 · Cited by 679
Sniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.959247 · Cited by 659
Grandi, S. M., Filion, K. B., Yoon, S., Ayele, H. T., Doyle, C. M., Hutcheon, J. A., Smith, G. N., Gore, G. C., Ray, J. G., Nerenberg, K., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036748 · Cited by 610
Sabatine, M. S., Leiter, L. A., Wiviott, S. D., Giugliano, R. P., Deedwania, P., De Ferrari, G. M., Murphy, S. A., Kuder, J. F., Gouni-Berthold, I., Lewis, B. S., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30313-3 · Cited by 603
Self-citationLangsted, A., Freiberg, J. J., & Nordestgaard, B. G. (2008) · Circulation · doi:10.1161/circulationaha.108.804146 · Cited by 588
Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events
Boekholdt, S. M., Hovingh, G. K., Mora, S., Arsenault, B. J., Amarenco, P., Pedersen, T. R., LaRosa, J. C., Waters, D. D., DeMicco, D. A., Simes, R. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.615 · Cited by 581
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Bittner, V. A., Szarek, M., Aylward, P. E., Bhatt, D. L., Diaz, R., Edelberg, J. M., Fras, Z., Goodman, S. G., Halvorsen, S., Hanotin, C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.057 · Cited by 572
Impact of Statins on Serial Coronary Calcification During Atheroma Progression and Regression
Puri, R., Nicholls, S. J., Shao, M., Kataoka, Y., Uno, K., Kapadia, S. R., Tuzcu, E. M., & Nissen, S. E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.036 · Cited by 571
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
Amarenco, P., Kim, J. S., Labreuche, J., Charles, H., Abtan, J., Béjot, Y., Cabrejo, L., Cha, J.-K., Ducrocq, G., Giroud, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910355 · Cited by 567
Kastelein, J. J. P., Ginsberg, H. N., Langslet, G., Hovingh, G. K., Ceska, R., Dufour, R., Blom, D., Civeira, F., Krempf, M., Lorenzato, C., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv370 · Cited by 533
Nissen, S. E., Stroes, E., Dent-Acosta, R. E., Rosenson, R. S., Lehman, S. J., Sattar, N., Preiss, D., Bruckert, E., Ceška, R., Lepor, N., et al. (2016) · JAMA · doi:10.1001/jama.2016.3608 · Cited by 522
Afshin, A., Micha, R., Khatibzadeh, S., & Mozaffarian, D. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.076901 · Cited by 509
Atherogenic Lipoprotein Particles in Atherosclerosis
Carmena, R., Duriez, P., & Fruchart, J.-C. (2004) · Circulation · doi:10.1161/01.cir.0000131511.50734.44 · Cited by 494
Chiuve, S. E., McCullough, M. L., Sacks, F. M., & Rimm, E. B. (2006) · Circulation · doi:10.1161/circulationaha.106.621417 · Cited by 477
Moriarty, P. M., Thompson, P. D., Cannon, C. P., Guyton, J. R., Bergeron, J., Zieve, F. J., Bruckert, E., Jacobson, T. A., Kopecky, S. L., Baccara-Dinet, M. T., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.08.006 · Cited by 470
Impact of Coronary Artery Calcium Scanning on Coronary Risk Factors and Downstream Testing
Rozanski, A., Gransar, H., Shaw, L. J., Kim, J., Miranda-Peats, L., Wong, N. D., Rana, J. S., Orakzai, R., Hayes, S. W., Friedman, J. D., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.019 · Cited by 458
Peters, S. A. E., den Ruijter, H. M., Bots, M. L., & Moons, K. G. M. (2012) · Heart · doi:10.1136/heartjnl-2011-300747 · Cited by 415
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub4 · Cited by 405
Villines, T. C., Hulten, E. A., Shaw, L. J., Goyal, M., Dunning, A., Achenbach, S., Al-Mallah, M., Berman, D. S., Budoff, M. J., Cademartiri, F., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.851 · Cited by 398
Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups
Paré, G., Çaku, A., McQueen, M., Anand, S. S., Enas, E., Clarke, R., Boffa, M. B., Koschinsky, M., Wang, X., Yusuf, S., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.034311 · Cited by 382
Kathiresan, S., Otvos, J. D., Sullivan, L. M., Keyes, M. J., Schaefer, E. J., Wilson, P. W. F., D’Agostino, R. B., Vasan, R. S., & Robins, S. J. (2006) · Circulation · doi:10.1161/circulationaha.105.567107 · Cited by 318
Gencer, B., Marston, N. A., Im, K., Cannon, C. P., Sever, P., Keech, A., Braunwald, E., Giugliano, R. P., & Sabatine, M. S. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32332-1 · Cited by 318
Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., Budaj, A. J., Diaz, R., Goodman, S. G., Hanotin, C., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30158-5 · Cited by 315
Self-citationSilverman, M. G., Blaha, M. J., Krumholz, H. M., Budoff, M. J., Blankstein, R., Sibley, C. T., Agatston, A., Blumenthal, R. S., & Nasir, K. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht508 · Cited by 308
Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis
Eslick, G. D., Howe, P. R. C., Smith, C., Priest, R., & Bensoussan, A. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.03.092 · Cited by 299
Fasting Time and Lipid Levels in a Community-Based Population: A Cross-sectional Study
Sidhu, D., & Naugler, C. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.3708 · Cited by 293
Madsen, C. M., Kamstrup, P. R., Langsted, A., Varbo, A., & Nordestgaard, B. G. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312951 · Cited by 280
Elevated Lipoprotein(a) and Risk of Ischemic Stroke
Langsted, A., Nordestgaard, B. G., & Kamstrup, P. R. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.524 · Cited by 269
Langlois, M. R., Chapman, M. J., Cobbaert, C., Mora, S., Remaley, A. T., Ros, E., Watts, G. F., Borén, J., Baum, H., Bruckert, E., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.287037 · Cited by 260
Lipoprotein (a): impact by ethnicity and environmental and medical conditions
Enkhmaa, B., Anuurad, E., & Berglund, L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r051904 · Cited by 260
Sabatine, M. S., De Ferrari, G. M., Giugliano, R. P., Huber, K., Lewis, B. S., Ferreira, J., Kuder, J. F., Murphy, S. A., Wiviott, S. D., Kurtz, C. E., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034309 · Cited by 255
Nordestgaard, B. G., Langlois, M. R., Langsted, A., Chapman, M. J., Aakre, K. M., Baum, H., Borén, J., Bruckert, E., Catapano, A., Cobbaert, C., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.12.005 · Cited by 246
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome
Jukema, J. W., Szarek, M., Zijlstra, L. E., de Silva, H. A., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.013 · Cited by 243
Taguchi, I., Iimuro, S., Iwata, H., Takashima, H., Abe, M., Amiya, E., Ogawa, T., Ozaki, Y., Sakuma, I., Nakagawa, Y., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032615 · Cited by 243
Central Nervous System and Limb Anomalies in Case Reports of First-Trimester Statin Exposure
Edison, R. J., & Muenke, M. (2004) · New England Journal of Medicine · doi:10.1056/nejm200404083501524 · Cited by 240
Statins and congenital malformations: cohort study
Bateman, B. T., Hernandez-Diaz, S., Fischer, M. A., Seely, E. W., Ecker, J. L., Franklin, J. M., Desai, R. J., Allen-Coleman, C., Mogun, H., Avorn, J., et al. (2015) · BMJ · doi:10.1136/bmj.h1035 · Cited by 236
Jenkins, D. J. A., Jones, P. J. H., Lamarche, B., Kendall, C. W. C., Faulkner, D., Cermakova, L., Gigleux, I., Ramprasath, V., de Souza, R., Ireland, C., et al. (2011) · JAMA · doi:10.1001/jama.2011.1202 · Cited by 218
Self-citationDeterminants of Coronary Calcium Conversion Among Patients With a Normal Coronary Calcium Scan
Min, J. K., Lin, F. Y., Gidseg, D. S., Weinsaft, J. W., Berman, D. S., Shaw, L. J., Rozanski, A., & Callister, T. Q. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.088 · Cited by 208
Kwok, C. S., Umar, S., Myint, P. K., Mamas, M. A., & Loke, Y. K. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.07.080 · Cited by 205
Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab
Robinson, J. G., Rosenson, R. S., Farnier, M., Chaudhari, U., Sasiela, W. J., Merlet, L., Miller, K., & Kastelein, J. J. P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.037 · Cited by 197
Welsh, C., Celis-Morales, C. A., Brown, R., Mackay, D. F., Lewsey, J., Mark, P. B., Gray, S. R., Ferguson, L. D., Anderson, J. J., Lyall, D. M., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.041149 · Cited by 191
Wilkins, J. T., Li, R. C., Sniderman, A., Chan, C., & Lloyd-Jones, D. M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.055 · Cited by 181
Gupta, A., Lau, E., Varshney, R., Hulten, E. A., Cheezum, M., Bittencourt, M. S., Blaha, M. J., Wong, N. D., Blumenthal, R. S., Budoff, M. J., et al. (2017) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2017.01.030 · Cited by 181
Mirrahimi, A., de Souza, R. J., Chiavaroli, L., Sievenpiper, J. L., Beyene, J., Hanley, A. J., Augustin, L. S. A., Kendall, C. W. C., & Jenkins, D. J. A. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.000752 · Cited by 161
Self-citationMahabadi, A. A., Möhlenkamp, S., Lehmann, N., Kälsch, H., Dykun, I., Pundt, N., Moebus, S., Jöckel, K., & Erbel, R. M. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2016.03.022 · Cited by 160
Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018
Brunham, L. R., Ruel, I. L., Aljenedil, S., Rivière, J., Baass, A. W., Tu, J. V., Mancini, G. B. J., Raggi, P., Gupta, M., Couture, P., et al. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.09.005 · Cited by 153
Self-citationMiname, M. H., Bittencourt, M. S., de Moraes, S. R., Alves, R. I. M., Silva, P. R. S., Jannes, C. E., Pereira, A. C., Krieger, J. E., Nasir, K., & Santos, R. D. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.09.019 · Cited by 151
Bernstein, A. M., Ding, E. L., Willett, W. C., & Rimm, E. B. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.148973 · Cited by 148
Hagiwara, N., Kawada-Watanabe, E., Koyanagi, R., Arashi, H., Yamaguchi, J., Nakao, K., Tobaru, T., Tanaka, H., Oka, T., Endoh, Y., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx162 · Cited by 136
Recurrent pre-eclampsia and subsequent cardiovascular risk
Auger, N., Fraser, W. D., Schnitzer, M. E., Leduc, L., Healy‐Profitós, J., & Paradis, G. (2016) · Heart · doi:10.1136/heartjnl-2016-309671 · Cited by 125
Blaha, M. J., Silverman, M. G., & Budoff, M. J. (2014) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.113.000341 · Cited by 114
Pregnancy outcomes after maternal exposure to simvastatin and lovastatin
Pollack, P. S., Shields, K. E., Burnett, D. M., Osborne, M. J., Cunningham, M. L., & Stepanavage, M. E. (2005) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20181 · Cited by 112
Grand’Maison, S., Pilote, L., Okano, M., Landry, T., & Dayan, N. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07907 · Cited by 106
Self-citationLipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk
Langsted, A., Kamstrup, P. R., & Nordestgaard, B. G. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.049 · Cited by 103
Hong, J. C., Blankstein, R., Shaw, L. J., Padula, W. V., Arrieta, A., Fialkow, J. A., Blumenthal, R. S., Blaha, M. J., Krumholz, H. M., & Nasir, K. (2017) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2017.04.014 · Cited by 101
Meta-Analysis of the Association Between Whole Grain Intake and Coronary Heart Disease Risk
Tang, G., Wang, D., Long, J., Yang, F., & Si, L. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.12.015 · Cited by 94
Pan, Y., Li, H., Wang, Y., Meng, X., & Wang, Y. (2019) · Stroke · doi:10.1161/strokeaha.119.026872 · Cited by 92
Gencer, B., Mach, F., Murphy, S. A., Ferrari, G. M. D., Huber, K., Lewis, B. S., Ferreira, J., Kurtz, C. E., Wang, H., Honarpour, N., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0882 · Cited by 91
Interplay of Coronary Artery Calcium and Risk Factors for Predicting CVD/CHD Mortality
Grandhi, G. R., Mirbolouk, M., Dardari, Z., Al-Mallah, M. H., Rumberger, J. A., Shaw, L. J., Blankstein, R., Miedema, M. D., Berman, D. S., Budoff, M. J., et al. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.08.024 · Cited by 89
Statin Trials, Cardiovascular Events, and Coronary Artery Calcification
Mortensen, M. B., Falk, E., Li, D., Nasir, K., Blaha, M. J., Sandfort, V., Rodriguez, C. J., Ouyang, P., & Budoff, M. (2018) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2017.01.029 · Cited by 88
McEvoy, J. W., Blaha, M. J., Rivera, J. J., Budoff, M. J., Khan, A. N., Shaw, L. J., Berman, D. S., Raggi, P., Min, J. K., Rumberger, J. A., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.02.017 · Cited by 87
Thanassoulis, G., Williams, K., Altobelli, K. K., Pencina, M. J., Cannon, C. P., & Sniderman, A. D. (2016) · Circulation · doi:10.1161/circulationaha.115.018383 · Cited by 87
Self-citationBlaha, M. J., Cainzos‐Achirica, M., Dardari, Z., Blankstein, R., Shaw, L. J., Rozanski, A., Rumberger, J. A., Dzaye, O. D. A., Michos, E. D., Berman, D. S., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.11.008 · Cited by 86
DEEDWANIA, P. C., Murphy, S. A., Scheen, A. J., Badarienė, J., Pineda, A. L., Honarpour, N., KEECH, A. C., Sever, P., Pedersen, T. R., Sabatine, M. S., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.3151 · Cited by 85
Mortensen, M. B., & Nordestgaard, B. G. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3665 · Cited by 78
Orimoloye, O. A., Budoff, M. J., Dardari, Z., Mirbolouk, M., Uddin, S. M. I., Berman, D. S., Rozanski, A., Shaw, L. J., Rumberger, J. A., Nasir, K., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010471 · Cited by 77
Smith, G. N., Pudwell, J., & Roddy, M. (2013) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30841-0 · Cited by 73
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery
Goodman, S. G., Aylward, P. E., Szarek, M. J., Chumburidze, V., Bhatt, D. L., Bittner, V., Díaz, R., Edelberg, J. M., Hanotin, C., Harrington, R. A., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.015 · Cited by 71
Primary Prevention With Statins
Mortensen, M. B., Afzal, S., Nordestgaard, B. G., & Falk, E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.089 · Cited by 69
Perera, R., McFadden, E. C., McLellan, J., Lung, T. W.-C., Clarke, P., Pérez, T., Fanshawe, T. R., Dalton, A., Farmer, A. A., Glasziou, P., et al. (2015) · Health Technology Assessment · doi:10.3310/hta191000 · Cited by 64
Gamble, D. T., Brikinns, B., Myint, P. K., & Bhattacharya, S. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00055 · Cited by 54
Al‐Nasiry, S., Ghossein‐Doha, C., Polman, S., Lemmens, S. M. P., Scholten, R. R., Heidema, W. M., Spaan, J. J., & Spaanderman, M. E. A. (2014) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13117 · Cited by 49
Prognostic value of lipoprotein (a) level in patients with coronary artery disease: a meta-analysis
Wang, Z., Zhai, X., Xue, M., Cheng, W., & Hu, H. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1092-6 · Cited by 47
Dudum, R., Dzaye, O. D. A., Mirbolouk, M., Dardari, Z., Orimoloye, O. A., Budoff, M. J., Berman, D. S., Rozanski, A., Miedema, M. D., Nasir, K., et al. (2019) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2019.03.012 · Cited by 45
Turgeon, R. D., Tsuyuki, R. T., Gyenes, G. T., & Pearson, G. J. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.04.002 · Cited by 43
Self-citationMöhlenkamp, S., Lehmann, N., Greenland, P., Moebus, S., Kälsch, H., Schmermund, A., Dragano, N., Stang, A., Siegrist, J., Mann, K., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.12.014 · Cited by 42
Lipoprotein(a) Levels in Patients With Abdominal Aortic Aneurysm
Kotani, K., Sahebkar, A., Șerban, M.-C., Ursoniu, S., Mikhailidis, D. P., Mariscalco, G., Jones, S. R., Martin, S. S., Blaha, M. J., Toth, P. P., et al. (2016) · Angiology · doi:10.1177/0003319716637792 · Cited by 41
Cohen, R. E., Budoff, M. J., McClelland, R. L., Sillau, S., Burke, G. L., Blaha, M. J., Szklo, M., Uretsky, S., Rozanski, A., & Shea, S. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.043 · Cited by 38
Dayan, N., Schlosser, K., Stewart, D. J., Delles, C., Kaur, A., & Pilote, L. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy069 · Cited by 31
Self-citationLipoprotein (a): Coming of Age at Last
Witztum, J. L., & Ginsberg, H. N. (2016) · Journal of Lipid Research · doi:10.1194/jlr.e066985 · Cited by 27
Efficacy and safety of PCSK9 monoclonal antibodies
Iqbal, Z., Dhage, S. S., Mohamad, J. B., Abdel-Razik, A. E. S., Donn, R. P., Malik, R. A., Ho, J. H., Liu, Y., Adam, S., Isa, B., et al. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1681395 · Cited by 26
Miname, M. H., Bittencourt, M. S., Pereira, A. C., Jannes, C. E., Krieger, J. E., Nasir, K., & Santos, R. D. (2019) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jez280 · Cited by 22
Alashi, A., Lang, R. S., Seballos, R. J., Feinleib, S. E., Sukol, R. B., Cho, L., Schoenhagen, P., Griffin, B. P., Flamm, S. D., & Desai, M. Y. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.04.05 · Cited by 17
Monoclonal Antibodies for the Treatment of Hypercholesterolemia: Targeting PCSK9
Alkindi, M., Siminovitch, K. A., Gupta, M., & Genest, J. J. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.04.013 · Cited by 15
Self-citationKodama, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.999 · Cited by 5
Cited by
Kronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., Dweck, M. R., Koschinsky, M., Lambert, G., Mach, F., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac361 · Cited by 1,449
Reyes-Soffer, G., Ginsberg, H. N., Berglund, L., Duell, P. B., Heffron, S. P., Kamstrup, P. R., Lloyd-Jones, D. M., Marcovina, S. M., Yeang, C., Koschinsky, M. L., et al. (2022) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0000000000000147 · Cited by 836
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
O’Donoghue, M. L., Rosenson, R. S., Gencer, B., López, J. A. G., Lepor, N. E., Baum, S. J., Stout, E., Gaudet, D., Knusel, B., Kuder, J. F., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2211023 · Cited by 599
A Modern Approach to Dyslipidemia
Berberich, A. J., & Hegele, R. A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab037 · Cited by 469
Self-citationLipoprotein(a) and its Significance in Cardiovascular Disease: A Review
Duarte Lau, F., & Giugliano, R. P. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.0987 · Cited by 363
Metadata
- Authors
- Pearson, G. J., Thanassoulis, G., Anderson, T. J., Barry, A. R., Couture, P., Dayan, N., Francis, G. A., Genest, J., Grégoire, J., Grover, S. A., Gupta, M., Hegele, R. A., Lau, D., Leiter, L. A., Leung, A. A., Lonn, E., Mancini, G. B. J., Manjoo, P., McPherson, R., Ngui, D., Piché, M.-E., Poirier, P., Sievenpiper, J., Stone, J., Ward, R., & Wray, W.
- Venue
- Canadian Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 37
- Issue
- 8
- Pages
- 1129-1150
- ISSN
- 0828-282X (ISSN-L)
- OpenAlex
- W4206654024
- Cited by
- 843
- References
- 131
- FWCI
- 125.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.